IBDEI0DF ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6072,1,5,0)
 ;;=5^Pos GMA Interferon w/o Active TB
 ;;^UTILITY(U,$J,358.3,6072,2)
 ;;=^340573
 ;;^UTILITY(U,$J,358.3,6073,0)
 ;;=466.0^^31^405^4
 ;;^UTILITY(U,$J,358.3,6073,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6073,1,4,0)
 ;;=4^466.0
 ;;^UTILITY(U,$J,358.3,6073,1,5,0)
 ;;=5^Acute Bronchitis
 ;;^UTILITY(U,$J,358.3,6073,2)
 ;;=^259084
 ;;^UTILITY(U,$J,358.3,6074,0)
 ;;=465.9^^31^405^6
 ;;^UTILITY(U,$J,358.3,6074,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6074,1,4,0)
 ;;=4^465.9
 ;;^UTILITY(U,$J,358.3,6074,1,5,0)
 ;;=5^Acute URI NOS
 ;;^UTILITY(U,$J,358.3,6074,2)
 ;;=^269878
 ;;^UTILITY(U,$J,358.3,6075,0)
 ;;=493.90^^31^405^9
 ;;^UTILITY(U,$J,358.3,6075,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6075,1,4,0)
 ;;=4^493.90
 ;;^UTILITY(U,$J,358.3,6075,1,5,0)
 ;;=5^Asthma w/o Status Asthmaticus
 ;;^UTILITY(U,$J,358.3,6075,2)
 ;;=^330091
 ;;^UTILITY(U,$J,358.3,6076,0)
 ;;=799.01^^31^405^8
 ;;^UTILITY(U,$J,358.3,6076,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6076,1,4,0)
 ;;=4^799.01
 ;;^UTILITY(U,$J,358.3,6076,1,5,0)
 ;;=5^Asphyxia
 ;;^UTILITY(U,$J,358.3,6076,2)
 ;;=^11005
 ;;^UTILITY(U,$J,358.3,6077,0)
 ;;=491.9^^31^405^20
 ;;^UTILITY(U,$J,358.3,6077,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6077,1,4,0)
 ;;=4^491.9
 ;;^UTILITY(U,$J,358.3,6077,1,5,0)
 ;;=5^Chronic Bronchitis NOS
 ;;^UTILITY(U,$J,358.3,6077,2)
 ;;=^24359
 ;;^UTILITY(U,$J,358.3,6078,0)
 ;;=473.9^^31^405^21
 ;;^UTILITY(U,$J,358.3,6078,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6078,1,4,0)
 ;;=4^473.9
 ;;^UTILITY(U,$J,358.3,6078,1,5,0)
 ;;=5^Chronic Sinusitis NOS
 ;;^UTILITY(U,$J,358.3,6078,2)
 ;;=^123985
 ;;^UTILITY(U,$J,358.3,6079,0)
 ;;=496.^^31^405^15
 ;;^UTILITY(U,$J,358.3,6079,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6079,1,4,0)
 ;;=4^496.
 ;;^UTILITY(U,$J,358.3,6079,1,5,0)
 ;;=5^COPD
 ;;^UTILITY(U,$J,358.3,6079,2)
 ;;=^24355
 ;;^UTILITY(U,$J,358.3,6080,0)
 ;;=799.02^^31^405^30
 ;;^UTILITY(U,$J,358.3,6080,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6080,1,4,0)
 ;;=4^799.02
 ;;^UTILITY(U,$J,358.3,6080,1,5,0)
 ;;=5^Hypoxemia
 ;;^UTILITY(U,$J,358.3,6080,2)
 ;;=^332831
 ;;^UTILITY(U,$J,358.3,6081,0)
 ;;=V12.51^^31^405^35
 ;;^UTILITY(U,$J,358.3,6081,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6081,1,4,0)
 ;;=4^V12.51
 ;;^UTILITY(U,$J,358.3,6081,1,5,0)
 ;;=5^Persl HX Pulm Embolism
 ;;^UTILITY(U,$J,358.3,6081,2)
 ;;=^303397
 ;;^UTILITY(U,$J,358.3,6082,0)
 ;;=491.0^^31^405^45
 ;;^UTILITY(U,$J,358.3,6082,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6082,1,4,0)
 ;;=4^491.0
 ;;^UTILITY(U,$J,358.3,6082,1,5,0)
 ;;=5^Smoker's Bronchitis
 ;;^UTILITY(U,$J,358.3,6082,2)
 ;;=^269946
 ;;^UTILITY(U,$J,358.3,6083,0)
 ;;=508.2^^31^405^41
 ;;^UTILITY(U,$J,358.3,6083,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6083,1,4,0)
 ;;=4^508.2
 ;;^UTILITY(U,$J,358.3,6083,1,5,0)
 ;;=5^Resp Cond D/T Smoke Inhalation
 ;;^UTILITY(U,$J,358.3,6083,2)
 ;;=^340527
 ;;^UTILITY(U,$J,358.3,6084,0)
 ;;=385.30^^31^405^18
 ;;^UTILITY(U,$J,358.3,6084,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6084,1,4,0)
 ;;=4^385.30
 ;;^UTILITY(U,$J,358.3,6084,1,5,0)
 ;;=5^Cholesteatoma NOS
 ;;^UTILITY(U,$J,358.3,6084,2)
 ;;=^23487
 ;;^UTILITY(U,$J,358.3,6085,0)
 ;;=784.7^^31^405^25
 ;;^UTILITY(U,$J,358.3,6085,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6085,1,4,0)
 ;;=4^784.7
 ;;^UTILITY(U,$J,358.3,6085,1,5,0)
 ;;=5^Epistaxis
 ;;^UTILITY(U,$J,358.3,6085,2)
 ;;=^41658
 ;;^UTILITY(U,$J,358.3,6086,0)
 ;;=518.82^^31^405^7
 ;;^UTILITY(U,$J,358.3,6086,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6086,1,4,0)
 ;;=4^518.82
 ;;^UTILITY(U,$J,358.3,6086,1,5,0)
 ;;=5^Adult Resp Distress Syndrome
 ;;
 ;;$END ROU IBDEI0DF
